Transparency notifications

Brussels (Belgium), 1 February 2017 – 20:00 (CET) – regulated information

1. Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications dated 27 and 30 January 2017 respectively, from BlackRock, Inc. (having its registered offices at 55 East 52nd Street, New York, NY, 10055, U.S.A.).

In the first notification, BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV had increased and had crossed the 3% threshold on 26 January 2017. In the second notification, BlackRock, Inc. has informed that, following a disposal of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV has decreased and has crossed downward the 3% threshold on 27 January 2017.

On 26 January 2017, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 858 144 UCB shares with voting rights (versus 5 783 437 UCB shares in its previous notification dated 19 January 2017), representing 3.01% of the total number of shares issued by the company (194 505 658) (versus 2.97% in the notification dated 19 January 2017).

On 27 January 2017, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 744 828 UCB shares with voting rights, representing 2.95% of the total number of shares issued by the company.

2. Content of the notifications

The transparency notification dated 27 January 2017 includes the following information:

• Date on which the threshold is crossed: 26 January 2017.
• Notified details:

• Additional information:

The disclosure obligation arose due to voting rights for BlackRock, Inc. going above 3%.

The transparency notification dated 30 January 2017 includes the following information:

• Date on which the threshold is crossed: 27 January 2017.
• Notified details:

• Additional information:

The disclosure obligation arose due to voting rights for BlackRock, Inc. going below 3%.

The information mentioned hereafter was identical in both notifications:

• Reason for the notification: Acquisition or disposal of voting securities or voting rights.
• Notification by: A parent undertaking or a controlling person.
• Persons subject to the notification requirement:

• Threshold crossed (in %): 3%.
• Denominator: 194 505 658.
• Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the PDF which is attached to the notifications.

3. Further information

This press release and the detailed transparency notifications are available on UCB SA/NV’s website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be included in the corporate governance charter of UCB SA/NV, which is available on its website via the following link.

Investor Relations

Antje Witte         
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
 Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com
 
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 3.9 billion in 2015. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news